世界の原発性免疫不全症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Primary Immunodeficiency Diseases Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4789
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、原発性免疫不全症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫グロブリン療法、抗生物質、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・原発性免疫不全症治療の市場動向
・企業の競争状況、市場シェア
・原発性免疫不全症治療の種類別市場規模（免疫グロブリン療法、抗生物質、その他）
・原発性免疫不全症治療の用途別市場規模（病院、診療所、その他）
・原発性免疫不全症治療の北米市場規模2016-2027（アメリカ、カナダ）
・原発性免疫不全症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・原発性免疫不全症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・原発性免疫不全症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・原発性免疫不全症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（CSL Behring、Grifols、Pfizer、Takeda、Abbott、ADMA Biologics、Astellas、AstraZeneca、Baxter、Bayer、Bristol-Myers Squibb、Eli Lilly）
・結論

Market Analysis and Insights: Global Primary Immunodeficiency Diseases Treatment Market
The global Primary Immunodeficiency Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Primary Immunodeficiency Diseases Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Primary Immunodeficiency Diseases Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Primary Immunodeficiency Diseases Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Primary Immunodeficiency Diseases Treatment market.

Global Primary Immunodeficiency Diseases Treatment Scope and Market Size
Primary Immunodeficiency Diseases Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Primary Immunodeficiency Diseases Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunoglobulin therapy
Antibiotics
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
CSL Behring
Grifols
Pfizer
Takeda
Abbott
ADMA Biologics
Astellas
AstraZeneca
Baxter
Takeda

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Primary Immunodeficiency Diseases Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunoglobulin therapy
1.2.3 Antibiotics
1.2.4 Others
1.3 Market by Application
1.3.1 Global Primary Immunodeficiency Diseases Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Primary Immunodeficiency Diseases Treatment Market Perspective (2016-2027)
2.2 Primary Immunodeficiency Diseases Treatment Growth Trends by Regions
2.2.1 Primary Immunodeficiency Diseases Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Primary Immunodeficiency Diseases Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Primary Immunodeficiency Diseases Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Primary Immunodeficiency Diseases Treatment Industry Dynamic
2.3.1 Primary Immunodeficiency Diseases Treatment Market Trends
2.3.2 Primary Immunodeficiency Diseases Treatment Market Drivers
2.3.3 Primary Immunodeficiency Diseases Treatment Market Challenges
2.3.4 Primary Immunodeficiency Diseases Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Primary Immunodeficiency Diseases Treatment Players by Revenue
3.1.1 Global Top Primary Immunodeficiency Diseases Treatment Players by Revenue (2016-2021)
3.1.2 Global Primary Immunodeficiency Diseases Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Primary Immunodeficiency Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Primary Immunodeficiency Diseases Treatment Revenue
3.4 Global Primary Immunodeficiency Diseases Treatment Market Concentration Ratio
3.4.1 Global Primary Immunodeficiency Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Primary Immunodeficiency Diseases Treatment Revenue in 2020
3.5 Primary Immunodeficiency Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Primary Immunodeficiency Diseases Treatment Product Solution and Service
3.7 Date of Enter into Primary Immunodeficiency Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Primary Immunodeficiency Diseases Treatment Breakdown Data by Type
4.1 Global Primary Immunodeficiency Diseases Treatment Historic Market Size by Type (2016-2021)
4.2 Global Primary Immunodeficiency Diseases Treatment Forecasted Market Size by Type (2022-2027)

5 Primary Immunodeficiency Diseases Treatment Breakdown Data by Application
5.1 Global Primary Immunodeficiency Diseases Treatment Historic Market Size by Application (2016-2021)
5.2 Global Primary Immunodeficiency Diseases Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Primary Immunodeficiency Diseases Treatment Market Size (2016-2027)
6.2 North America Primary Immunodeficiency Diseases Treatment Market Size by Type
6.2.1 North America Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2021)
6.2.2 North America Primary Immunodeficiency Diseases Treatment Market Size by Type (2022-2027)
6.2.3 North America Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2027)
6.3 North America Primary Immunodeficiency Diseases Treatment Market Size by Application
6.3.1 North America Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2021)
6.3.2 North America Primary Immunodeficiency Diseases Treatment Market Size by Application (2022-2027)
6.3.3 North America Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2027)
6.4 North America Primary Immunodeficiency Diseases Treatment Market Size by Country
6.4.1 North America Primary Immunodeficiency Diseases Treatment Market Size by Country (2016-2021)
6.4.2 North America Primary Immunodeficiency Diseases Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Primary Immunodeficiency Diseases Treatment Market Size (2016-2027)
7.2 Europe Primary Immunodeficiency Diseases Treatment Market Size by Type
7.2.1 Europe Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2021)
7.2.2 Europe Primary Immunodeficiency Diseases Treatment Market Size by Type (2022-2027)
7.2.3 Europe Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2027)
7.3 Europe Primary Immunodeficiency Diseases Treatment Market Size by Application
7.3.1 Europe Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2021)
7.3.2 Europe Primary Immunodeficiency Diseases Treatment Market Size by Application (2022-2027)
7.3.3 Europe Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2027)
7.4 Europe Primary Immunodeficiency Diseases Treatment Market Size by Country
7.4.1 Europe Primary Immunodeficiency Diseases Treatment Market Size by Country (2016-2021)
7.4.2 Europe Primary Immunodeficiency Diseases Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size (2016-2027)
8.2 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Type
8.2.1 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Application
8.3.1 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Region
8.4.1 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Primary Immunodeficiency Diseases Treatment Market Size (2016-2027)
9.2 Latin America Primary Immunodeficiency Diseases Treatment Market Size by Type
9.2.1 Latin America Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Primary Immunodeficiency Diseases Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2027)
9.3 Latin America Primary Immunodeficiency Diseases Treatment Market Size by Application
9.3.1 Latin America Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Primary Immunodeficiency Diseases Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2027)
9.4 Latin America Primary Immunodeficiency Diseases Treatment Market Size by Country
9.4.1 Latin America Primary Immunodeficiency Diseases Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Primary Immunodeficiency Diseases Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size (2016-2027)
10.2 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Type
10.2.1 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Application
10.3.1 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Country
10.4.1 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Details
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring Primary Immunodeficiency Diseases Treatment Introduction
11.1.4 CSL Behring Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.1.5 CSL Behring Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Primary Immunodeficiency Diseases Treatment Introduction
11.2.4 Grifols Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.2.5 Grifols Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Primary Immunodeficiency Diseases Treatment Introduction
11.3.4 Pfizer Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Primary Immunodeficiency Diseases Treatment Introduction
11.4.4 Takeda Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Primary Immunodeficiency Diseases Treatment Introduction
11.5.4 Abbott Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 ADMA Biologics
11.6.1 ADMA Biologics Company Details
11.6.2 ADMA Biologics Business Overview
11.6.3 ADMA Biologics Primary Immunodeficiency Diseases Treatment Introduction
11.6.4 ADMA Biologics Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.6.5 ADMA Biologics Recent Development
11.7 Astellas
11.7.1 Astellas Company Details
11.7.2 Astellas Business Overview
11.7.3 Astellas Primary Immunodeficiency Diseases Treatment Introduction
11.7.4 Astellas Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.7.5 Astellas Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Primary Immunodeficiency Diseases Treatment Introduction
11.8.4 AstraZeneca Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Baxter
11.9.1 Baxter Company Details
11.9.2 Baxter Business Overview
11.9.3 Baxter Primary Immunodeficiency Diseases Treatment Introduction
11.9.4 Baxter Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.9.5 Baxter Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Primary Immunodeficiency Diseases Treatment Introduction
11.10.4 Bayer Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.10.5 Bayer Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Primary Immunodeficiency Diseases Treatment Introduction
11.11.4 Bristol-Myers Squibb Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Primary Immunodeficiency Diseases Treatment Introduction
11.12.4 Eli Lilly Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
11.12.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Primary Immunodeficiency Diseases Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunoglobulin therapy
Table 3. Key Players of Antibiotics
Table 4. Key Players of Others
Table 5. Global Primary Immunodeficiency Diseases Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Primary Immunodeficiency Diseases Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Primary Immunodeficiency Diseases Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Primary Immunodeficiency Diseases Treatment Market Share by Regions (2016-2021)
Table 9. Global Primary Immunodeficiency Diseases Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Primary Immunodeficiency Diseases Treatment Market Share by Regions (2022-2027)
Table 11. Primary Immunodeficiency Diseases Treatment Market Trends
Table 12. Primary Immunodeficiency Diseases Treatment Market Drivers
Table 13. Primary Immunodeficiency Diseases Treatment Market Challenges
Table 14. Primary Immunodeficiency Diseases Treatment Market Restraints
Table 15. Global Primary Immunodeficiency Diseases Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Primary Immunodeficiency Diseases Treatment Market Share by Players (2016-2021)
Table 17. Global Top Primary Immunodeficiency Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primary Immunodeficiency Diseases Treatment as of 2020)
Table 18. Ranking of Global Top Primary Immunodeficiency Diseases Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Primary Immunodeficiency Diseases Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Primary Immunodeficiency Diseases Treatment Product Solution and Service
Table 22. Date of Enter into Primary Immunodeficiency Diseases Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Primary Immunodeficiency Diseases Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Primary Immunodeficiency Diseases Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Primary Immunodeficiency Diseases Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Primary Immunodeficiency Diseases Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Primary Immunodeficiency Diseases Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Primary Immunodeficiency Diseases Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Primary Immunodeficiency Diseases Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Primary Immunodeficiency Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Primary Immunodeficiency Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Primary Immunodeficiency Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Primary Immunodeficiency Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Primary Immunodeficiency Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Primary Immunodeficiency Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Primary Immunodeficiency Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Primary Immunodeficiency Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Primary Immunodeficiency Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Primary Immunodeficiency Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Primary Immunodeficiency Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Primary Immunodeficiency Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. CSL Behring Company Details
Table 63. CSL Behring Business Overview
Table 64. CSL Behring Primary Immunodeficiency Diseases Treatment Product
Table 65. CSL Behring Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 66. CSL Behring Recent Development
Table 67. Grifols Company Details
Table 68. Grifols Business Overview
Table 69. Grifols Primary Immunodeficiency Diseases Treatment Product
Table 70. Grifols Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 71. Grifols Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Primary Immunodeficiency Diseases Treatment Product
Table 75. Pfizer Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Takeda Company Details
Table 78. Takeda Business Overview
Table 79. Takeda Primary Immunodeficiency Diseases Treatment Product
Table 80. Takeda Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 81. Takeda Recent Development
Table 82. Abbott Company Details
Table 83. Abbott Business Overview
Table 84. Abbott Primary Immunodeficiency Diseases Treatment Product
Table 85. Abbott Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 86. Abbott Recent Development
Table 87. ADMA Biologics Company Details
Table 88. ADMA Biologics Business Overview
Table 89. ADMA Biologics Primary Immunodeficiency Diseases Treatment Product
Table 90. ADMA Biologics Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 91. ADMA Biologics Recent Development
Table 92. Astellas Company Details
Table 93. Astellas Business Overview
Table 94. Astellas Primary Immunodeficiency Diseases Treatment Product
Table 95. Astellas Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 96. Astellas Recent Development
Table 97. AstraZeneca Company Details
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Baxter Company Details
Table 102. Baxter Business Overview
Table 103. Baxter Primary Immunodeficiency Diseases Treatment Product
Table 104. Baxter Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 105. Baxter Recent Development
Table 106. Bayer Company Details
Table 107. Bayer Business Overview
Table 108. Bayer Primary Immunodeficiency Diseases Treatment Product
Table 109. Bayer Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 110. Bayer Recent Development
Table 111. Bristol-Myers Squibb Company Details
Table 112. Bristol-Myers Squibb Business Overview
Table 113. Bristol-Myers Squibb Primary Immunodeficiency Diseases Treatment Product
Table 114. Bristol-Myers Squibb Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 115. Bristol-Myers Squibb Recent Development
Table 116. Eli Lilly Company Details
Table 117. Eli Lilly Business Overview
Table 118. Eli Lilly Primary Immunodeficiency Diseases Treatment Product
Table 119. Eli Lilly Revenue in Primary Immunodeficiency Diseases Treatment Business (2016-2021) & (US$ Million)
Table 120. Eli Lilly Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Primary Immunodeficiency Diseases Treatment Market Share by Type: 2020 VS 2027
Figure 2. Immunoglobulin therapy Features
Figure 3. Antibiotics Features
Figure 4. Others Features
Figure 5. Global Primary Immunodeficiency Diseases Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Primary Immunodeficiency Diseases Treatment Report Years Considered
Figure 10. Global Primary Immunodeficiency Diseases Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Primary Immunodeficiency Diseases Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Primary Immunodeficiency Diseases Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Primary Immunodeficiency Diseases Treatment Market Share by Regions (2022-2027)
Figure 14. Global Primary Immunodeficiency Diseases Treatment Market Share by Players in 2020
Figure 15. Global Top Primary Immunodeficiency Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primary Immunodeficiency Diseases Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Primary Immunodeficiency Diseases Treatment Revenue in 2020
Figure 17. Global Primary Immunodeficiency Diseases Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Primary Immunodeficiency Diseases Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Primary Immunodeficiency Diseases Treatment Market Share by Type (2016-2027)
Figure 21. North America Primary Immunodeficiency Diseases Treatment Market Share by Application (2016-2027)
Figure 22. North America Primary Immunodeficiency Diseases Treatment Market Share by Country (2016-2027)
Figure 23. United States Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Primary Immunodeficiency Diseases Treatment Market Share by Type (2016-2027)
Figure 27. Europe Primary Immunodeficiency Diseases Treatment Market Share by Application (2016-2027)
Figure 28. Europe Primary Immunodeficiency Diseases Treatment Market Share by Country (2016-2027)
Figure 29. Germany Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Primary Immunodeficiency Diseases Treatment Market Share by Region (2016-2027)
Figure 39. China Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Primary Immunodeficiency Diseases Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Primary Immunodeficiency Diseases Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Primary Immunodeficiency Diseases Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Primary Immunodeficiency Diseases Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Primary Immunodeficiency Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. CSL Behring Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 59. Grifols Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 61. Takeda Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 63. ADMA Biologics Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 64. Astellas Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 66. Baxter Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Primary Immunodeficiency Diseases Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Primary Progressive Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4790 2021年4月 94Pages
QYResearch社発行の本調査資料では、一次進行性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、ラキニモドナトリウム、その他）、用途別市場規模（病院、診療所、...

世界のヒト免疫不全ウイルス（HIV）市場規模・現状・予測（2021年-2027年）

Global Human Immunodeficiency Virus (HIV) Market Size, Status and Forecast 2021-2027
QYR2104Z2948 2021年4月 90Pages
QYResearch社発行の本調査資料では、ヒト免疫不全ウイルス（HIV）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、外来手術センター、診断センター、在宅医療施設、その他）、主要地域別市場規模（北米、アメ...

世界の感染性疾患治療市場規模・現状・予測（2021年-2027年）

Global Communicable Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1490 2021年4月 93Pages
QYResearch社発行の本調査資料では、感染性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HIV、インフルエンザ、結核、マラリア、肝炎、HPV）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の伝染病治療市場規模・現状・予測（2021年-2027年）

Global Treatment for Communicable Diseases Market Size, Status and Forecast 2021-2027
QYR2104Z5738 2021年4月 96Pages
QYResearch社発行の本調査資料では、伝染病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HIV、インフルエンザ、結核、マラリア、肝炎、HPV）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の孤児肺疾患治療市場規模・現状・予測（2021年-2027年）

Global Orphan Lung Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4327 2021年4月 92Pages
QYResearch社発行の本調査資料では、孤児肺疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、抗炎症剤、抗線維化剤、血管拡張剤、コルチコステロイド、CFTRモジュレーター、その他）、用途別市場規模（病院薬局、ドラッグスト...

世界の運動ニューロン病治療市場規模・現状・予測（2021年-2027年）

Global Motor Neuron Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3924 2021年4月 94Pages
QYResearch社発行の本調査資料では、運動ニューロン病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リルゾール、ヌシネルセン、理学療法、呼吸療法、その他）、用途別市場規模（総合クリニック、病院、社会福祉施設、その他）、主要地域別市場...

世界の豚病気治療市場規模・現状・予測（2021年-2027年）

Global Swine Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5522 2021年4月 96Pages
QYResearch社発行の本調査資料では、豚病気治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（滲出性皮膚炎、コクシジウム症、呼吸器疾患、豚赤痢、乳腺炎、ブタパルボウイルス）、用途別市場規模（私立獣医病院、私立獣医薬局、政府獣医クリニック...

世界の慢性肺疾患治療市場規模・現状・予測（2021年-2027年）

Global Chronic Lung Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1319 2021年4月 96Pages
QYResearch社発行の本調査資料では、慢性肺疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、カプセル、錠剤、その他）、用途別市場規模（気管支肺異形成症、喘息、COPD、肺線維症）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の免疫性炎症性疾患治療市場規模・現状・予測（2021年-2027年）

Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3045 2021年4月 90Pages
QYResearch社発行の本調査資料では、免疫性炎症性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物学的療法、新規療法）、用途別市場規模（病院、薬局、オンライン薬局ストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の筋骨格系疾患治療市場規模・現状・予測（2021年-2027年）

Global Musculoskeletal Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3973 2021年4月 99Pages
QYResearch社発行の本調査資料では、筋骨格系疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（磁気共鳴画像法（MRI）、コンピューター断層撮影（CT）、超音波、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規...

世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Primary Progressive Multiple Sclerosis Treatment Market The global Primary Progressive Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…
世界の原発性線毛機能不全市場規模・現状・予測（2021年-2027年） Primary ciliary dyskinesia (PCD), also called immotile ciliary syndrome or Kartagener syndrome, is a rare, ciliopathic, autosomal recessive genetic disorder that causes defects in the action of cilia lining the respiratory tract (lower and upper, sinuses, Eustachian tube, middle ear), fallopian tube…
世界の原発性アルドステロン症市場規模・現状・予測（2021年-2027年） Primary aldosteronism refers to the excess production of the hormone aldosterone from the adrenal glands, resulting in low renin levels. This abnormality is caused by hyperplasia or tumors. Many suffer from fatigue, potassium deficiency and high blood pressure which may cause poor vision, confusion …
世界の運動ニューロン病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Motor Neuron Diseases Treatment Market The global Motor Neuron Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
世界のヒト免疫不全ウイルス（HIV）市場規模・現状・予測（2021年-2027年） HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person c…